Literature DB >> 26794318

Vasohibins: new transglutaminase-like cysteine proteases possessing a non-canonical Cys-His-Ser catalytic triad.

Luis Sanchez-Pulido1, Chris P Ponting1.   

Abstract

UNLABELLED: Vasohibin-1 and Vasohibin-2 regulate angiogenesis, tumour growth and metastasis. Their molecular functions, however, were previously unknown, in large part owing to their perceived lack of homology to proteins of known structure and function. To identify their functional amino acids and domains, their molecular activity and their evolutionary history, we undertook an in-depth analysis of Vasohibin sequences. We find that Vasohibin proteins are previously undetected members of the transglutaminase-like cysteine protease superfamily, and all possess a non-canonical Cys-His-Ser catalytic triad. We further propose a calcium-dependent activation mechanism for Vasohibin proteins. These findings can now be used to design constructs for protein structure determination and to develop enzyme inhibitors as angiogenic regulators to treat metastasis and tumour growth. CONTACT: luis.sanchezpulido@dpag.ox.ac.uk SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author 2016. Published by Oxford University Press.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26794318      PMCID: PMC4866520          DOI: 10.1093/bioinformatics/btv761

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


1 Introduction

Tight regulation of angiogenesis contributes to normal physiology, growth and development, but when misregulated leads to, or dramatically affects, pathological conditions, such as ischaemia, wound healing and cancer (Ferrara and Kerbel, 2005). Angiogenesis is a fundamental step in transitioning tumours from benignancy to malignancy. The use of angiogenesis inhibitors in treating cancer has thus received considerable attention over the last four decades (Bergers and Benjamin, 2003). Vasohibin-1 (VASH1) was initially identified as a vascular endothelial growth factor inducible gene that regulates endothelial cell migration (Watanabe ; Sato, 2013; Sato, 2015). Despite lacking a classical secretion signal, human VASH1 protein is released extracellularly, assisted by a small vasohibin-binding protein which is the only known VASH1-interacting protein (Suzuki ). Over-expression of a paralogue, Vasohibin-2 (VASH2), is associated with diverse tumours, with major roles to angiogenesis, malignant transformation, and metastasis (Kim ; Kitahara ; Koyanagi ; Shibuya ; Takahashi ; Tu ; Xue ). Knockout mouse studies have revealed the contrasting roles of the two paralogues (Ito ). VASH1 is expressed in endothelial cells in zones within which angiogenesis is arrested, whilst VASH2 is expressed in infiltrating mononuclear cells at the sprouting front in which angiogenesis is enhanced (Kimura ). The molecular activity of neither paralogue is known, in large part due to a perceived lack of homology to proteins of known structure and function.

2 Results and discussion

2.1 Computational protein sequence analysis

We initiated our analyses by performing a JackHMMER iterative search (Finn ) starting from the human VASH1 protein sequence, against the UniRef50 database (Wu ). With the exception of fungi, the vasohibin family is widely distributed in eukaryotes: in animals it is represented from humans to placozoans (Trichoplax adhaerens), but is absent from nematodes (Caenorhabditis elegans) and hexapods (Drosophila melanogaster), and in plants homologues are present from green algae to Bryophytes (Physcomitrella patens) but are not in vascular plants. We identified an evolutionarily conserved central region in the vasohibin family, thereby reproducing this unusual phyletic distribution reported in Pfam (Family: vasohibin/PF14822) (Punta ). Vasohibin homologous sequences were identified in standard databases (UniProt, GenBank and Joint Genome Institute data) and in manually assembled ESTs and FGENESH+-predicted gene models (Solovyev ). Next, we took advantage of HMMer3 and HMMer2 (Eddy, 1996; Finn ) to search UniRef50 for more divergent vasohibin homologues using a hidden Markov model (HMM) generated from the central conserved region (corresponding to human VASH1, UniProt: VASH1_HUMAN, amino acids 125–247). With this profile, HMMer3 identified significant (E-value = 0.011) sequence similarities between the vasohibin HMM and a cryptophyte algae protein from Guillardia theta (UniProt: L1IQR7_GUITH, amino acids 120–227). This G. theta protein is a member of an experimentally uncharacterised family (henceforth, the ‘vasohibin-like’ family) drawn from phylogenetically heterogeneous organisms. These include Acidobacteria (Solibacter usitatus and Acidobacteriaceae bacterium), Proteobacteria (Bdellovibrio exovorus and Reyranella massiliensis), and eukaryotes (G. theta, Chaetosphaeridium globosum, Chlorokybus atmophyticus and the dinoflagellate Karlodinium veneficum; Fig. 1 and Supplementary Figure S1).
Fig. 1.

Multiple sequence alignment of representative vasohibin and related families. Multiple sequence alignments for each family were generated with the program T-Coffee (Notredame ) using default parameters and slightly refined manually. The final superfamily alignment was generated using a combination of profile-to-profile comparisons (Söding ) and sequence alignments derived from structural super-positions for those families whose tertiary structure is known (PDB IDs: 3isr, 2bsz, 4dmo and 4fgq) (Holm and Sander, 1995). Active site residues are labelled and coloured according to reference protein sequences: VASH1, NAT3 (human arylamine N-acetyltransferase 3), and calcium-dependent periplasmic cysteine protease LapG in red, pink and violet, respectively. A putative calcium-binding residue (human VASH1 E171) is labelled. Families are indicated by coloured bars to the left of the alignment: Vasohibin, Vasohibin-like and transglutaminase-like cysteine protease are indicated in red, yellow and purple, respectively. The limits of the protein sequences included in the alignment are indicated by flanking residue positions. Secondary structure predictions (Jones, 1999) were performed independently for the vasohibin and vasohibin-like families (show in ss_predVash and ss_predBac lanes); these are consistent with X-ray determined secondary structures of the putative cysteine protease from C. hutchinsonii (PDB: 3isr) (Stein et al., Midwest Center for Structural Genomics, unpublished), NAT1 (arylamine N-acetyltransferase-1) from Mesorhizobium loti (PDB: 2bsz) (Holton ), NAT3 (arylamine N-acetyltransferase-3) from Bacillus cereus (PDB: 4dmo) (Kubiak ) and the calcium-dependent periplasmic cysteine protease LapG from Legionella pneumophila (PDB: 4fgq) (Chatterjee ). Alpha-helices and beta-strands are indicated by cylinders and arrows, respectively. The alignment was presented with the program Belvu using a colouring scheme indicating the average BLOSUM62 scores (which are correlated with amino acid conservation) of each alignment column: red (>3), violet (between 3 and 1.5) and light yellow (between 1.5 and 0.5) (Sonnhammer and Hollich, 2005). Sequences are named according to their UniProt identification or common name (details provided in Supplementary Figure S1). Below the alignment are shown a homology-model of human VASH1 and known structures of representative members of the transglutaminase-like cysteine protease superfamily. Catalytic triads are labelled and side chains shown using sticks. The human VASH1 structural model was created using Modeller (Sali and Blundell, 1993). VASH1 model and structures are presented using Pymol (http://www.pymol.org)

Multiple sequence alignment of representative vasohibin and related families. Multiple sequence alignments for each family were generated with the program T-Coffee (Notredame ) using default parameters and slightly refined manually. The final superfamily alignment was generated using a combination of profile-to-profile comparisons (Söding ) and sequence alignments derived from structural super-positions for those families whose tertiary structure is known (PDB IDs: 3isr, 2bsz, 4dmo and 4fgq) (Holm and Sander, 1995). Active site residues are labelled and coloured according to reference protein sequences: VASH1, NAT3 (human arylamine N-acetyltransferase 3), and calcium-dependent periplasmic cysteine protease LapG in red, pink and violet, respectively. A putative calcium-binding residue (human VASH1 E171) is labelled. Families are indicated by coloured bars to the left of the alignment: Vasohibin, Vasohibin-like and transglutaminase-like cysteine protease are indicated in red, yellow and purple, respectively. The limits of the protein sequences included in the alignment are indicated by flanking residue positions. Secondary structure predictions (Jones, 1999) were performed independently for the vasohibin and vasohibin-like families (show in ss_predVash and ss_predBac lanes); these are consistent with X-ray determined secondary structures of the putative cysteine protease from C. hutchinsonii (PDB: 3isr) (Stein et al., Midwest Center for Structural Genomics, unpublished), NAT1 (arylamine N-acetyltransferase-1) from Mesorhizobium loti (PDB: 2bsz) (Holton ), NAT3 (arylamine N-acetyltransferase-3) from Bacillus cereus (PDB: 4dmo) (Kubiak ) and the calcium-dependent periplasmic cysteine protease LapG from Legionella pneumophila (PDB: 4fgq) (Chatterjee ). Alpha-helices and beta-strands are indicated by cylinders and arrows, respectively. The alignment was presented with the program Belvu using a colouring scheme indicating the average BLOSUM62 scores (which are correlated with amino acid conservation) of each alignment column: red (>3), violet (between 3 and 1.5) and light yellow (between 1.5 and 0.5) (Sonnhammer and Hollich, 2005). Sequences are named according to their UniProt identification or common name (details provided in Supplementary Figure S1). Below the alignment are shown a homology-model of human VASH1 and known structures of representative members of the transglutaminase-like cysteine protease superfamily. Catalytic triads are labelled and side chains shown using sticks. The human VASH1 structural model was created using Modeller (Sali and Blundell, 1993). VASH1 model and structures are presented using Pymol (http://www.pymol.org) Profile-versus-sequence (HMMer2 and HMMer3) (Eddy, 1996; Finn ) and profile-versus-profile (HHpred) (Söding ) similarity searches using an HMM representing the central conserved portion of the vasohibin-like family produced concordant results, identifying robust statistical significance (HMMer2 E-value = 0.03 and HMMer3 E-value = 1.2 × 10−5) for the sequence similarity between vasohibin and vasohibin-like families (Supplementary Figure S2). Unexpectedly, HHpred searches against the PDB70 profile database (Söding ), again using the conserved central region of the vasohibin-like family, matched the transglutaminase-like cysteine protease domain of Cytophaga hutchinsonii protein (PDB-ID: 3ISR) with a highly significant E-value of 6.5 × 10−4 (Fig. 1 and Supplementary Figure S2). Moreover, in support of this first match, the next most statistically significant matches were to five further members of the transglutaminase-like cysteine protease superfamily [PDB-IDs: 3KD4, 4FGQ (LapG), 2F4M, 2BSZ (NAT1) and 4DMO (NAT3)]. Many members of this superfamily are functionally and structurally characterized enzymes classified in different protein databases, such as: Pfam (Clan Peptidase_CA CL0125, containing 60 families), SCOP (Fold: Cysteine proteinases, subdivided in 22 families) and MEROPS database of peptidases (clan CA, carefully subdivided in 36 families) (Andreeva ; Punta ; Rawlings ). Additionally, secondary structure predictions of the vasohibin and vasohibin-like families corroborated this proposed homology because they yielded high similarity with known transglutaminase-like cysteine protease superfamily structures (Fig. 1).

2.2 Active site conservation, a non-canonical catalytic triad

Proteins of the transglutaminase-like cysteine protease superfamily catalyse various reactions (such as: transglutaminases, proteases, phytochelatin synthases and arylamine N-acetyltransferases) on diverse substrates. Nevertheless, they all contain a conserved catalytic triad (usually Cys-His-Asp/Glu) (Chatterjee ; Ginalski ; Keillor ; Makarova , 2000; Polgár and Asbóth, 1986; Vivares ). These amino acids are conserved as Cys-His-Ser/Thr in human VASH1 and all its homologues at sites that structurally superimpose onto the transglutaminase active centre residues (Fig. 1). This modified catalytic triad (Cys-His-Ser/Thr) thus appears to be essential for the normal function of the vasohibin family. Active sites and catalytic mechanisms of transglutaminase-like cysteine proteases have been extensively studied (Keillor ; Polgár and Asbóth, 1986). In the classical Cys-His-Asn/Asp catalytic triad, the Cys, activated as a thiolate anion by the His residue, plays the major role in the nucleophilic attack the substrate. Both positions, His and Cys, are completely conserved across all members of the vasohibin family (VASH1 residues C169 and H204) (Fig. 1). The third position of the catalytic triad (commonly Asn, Asp or Glu) is known to have a secondary role in catalysis by orienting the His side chain to allow the formation of a thiolate/imidazolium ion pair between Cys and His residues (Vernet ). Such a role, we suggest, could also be performed by the hydroxyl groups of the conserved Ser or Thr amino acids (VASH1 residue S221) (Fig. 1). This non-canonical catalytic triad (Cys-His-Ser/Thr) present in the Vasohibin family, is not unique to the transglutaminase-like cysteine protease superfamily, because members of the Transglut_core family (Pfam entry: PF01841) (Punta ), part of the transglutaminase-like cysteine protease superfamily, also contain a Cys-His-Thr non-canonical catalytic triad (e.g. A0LIH5_SYNFM from Syntrophobacter fumaroxidans). Another example of a non-canonical catalytic triad is the Cys-His-(O=C)Trp triad in mSpeB (PDB: 1dki) (Kagawa ), where the role of orienting the His residue is taken by the backbone carbonyl group of a Trp amino acid. Despite containing this unconventional catalytic triad, mSpeB is an unusually active protease (Honda-Ogawa ).

2.3 Activators, inhibitors and regulators in the Transglutaminase-like cysteine protease superfamily

Owing to the higher concentrations of calcium in the extracellular space, diverse secreted proteins possess calcium-dependent activation mechanisms that avoid intracellular activation. Calcium dependent activation is a recurring theme across the transglutaminase-like cysteine protease superfamily (Boyd ; Chatterjee ; Jang ). Calcium-binding sites show a wide range of geometries involving three or four-COOH groups (particularly aspartic and glutamic acids) plus two neutral oxygen donors (usually backbone atoms) (Wang ). A calcium-dependent activation mechanism in vasohibin homologues is suggested by the alignment of a conserved amino acid (VASH1-E171) with a known calcium binding residue in LapG protease (LapG-D139) (Fig. 1) (Chatterjee ). Experimental evidence will be necessary to confirm these Vasohibin family predicted calcium-binding sites. Angiogenesis is not a new cellular process for members of the transglutaminase-like cysteine protease superfamily. Tissue transglutaminase (also known as transglutaminase 2), for example, and also different members of the cysteine cathepsin family of peptidases, have been frequently implicated in various aspects of vascular morphogenesis (Turk ; Wang ). The identification of the Vasohibin family as members of the transglutaminase-like cysteine protease superfamily may further clarify the known relationship between reactive oxygen or nitrogen species (ROS and RNS) and angiogenesis (Huang and Zheng, 2006; Ushio-Fukai, 2007; Ushio-Fukai and Urao, 2009). ROS and RNS are known to inactivate different members of the transglutaminase-like cysteine protease superfamily, such as papain (Xian ), arylamine N-acetyltransferase (NAT1) (Dupret ) and transglutaminases (Bernassola ; Nurminskaya and Belkin, 2012). We thus suggest that the putative catalytic cysteine residues in VASH1 and VASH2 could be substrates of ROS and RNS activity. Owing to the enzymatic diversity of its transglutaminase-like homologues, our computational analysis is unable to predict the catalytic reaction or substrate of vasohibins. Nevertheless, the discovery of vasohibins as enzyme homologues should now motivate the determination of their protein structures and the development of active site inhibitors that differentiate VASH1 from VASH2. Such inhibitors would be anticipated to modify angiogenesis and thus to be useful for inhibiting metastasis and tumour growth. We note that different inhibitors have already been described for several members of the transglutaminase-like cysteine protease superfamily (Badarau ; Chakka ; Keillor ; Kerr ; Kukongviriyapan ; Pandey and Dixit, 2012; Sim ; Turk ; Zhou ).

3 Conclusion

Given the strong statistical significance of sequence and profile comparisons, and the concordance of secondary structure predictions and conserved active site residues, we have shown that vasohibin proteins are new members of the transglutaminase-like cysteine protease superfamily, and possess a non-canonical Cys-His-Ser/Thr catalytic triad. This insight should immediately help guide experiments to clarify the molecular mechanisms by which VASH1 and VASH2 control angiogenesis.

Funding

This work was supported by Medical Research Council UK. Conflict of Interest: none declared.
  61 in total

1.  Protein secondary structure prediction based on position-specific scoring matrices.

Authors:  D T Jones
Journal:  J Mol Biol       Date:  1999-09-17       Impact factor: 5.469

2.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

Review 3.  Regulation of transglutaminases by nitric oxide.

Authors:  F Bernassola; A Rossi; G Melino
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

Review 4.  Inhibitors of tissue transglutaminase.

Authors:  Jeffrey W Keillor; Kim Y P Apperley; Abdullah Akbar
Journal:  Trends Pharmacol Sci       Date:  2014-12-12       Impact factor: 14.819

5.  Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors.

Authors:  Mariko Honda-Ogawa; Taiji Ogawa; Yutaka Terao; Tomoko Sumitomo; Masanobu Nakata; Kazunori Ikebe; Yoshinobu Maeda; Shigetada Kawabata
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

6.  VEGF signaling through NADPH oxidase-derived ROS.

Authors:  Masuko Ushio-Fukai
Journal:  Antioxid Redox Signal       Date:  2007-06       Impact factor: 8.401

7.  Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin.

Authors:  Takumi Shibuya; Kazuhide Watanabe; Hiroshi Yamashita; Kazue Shimizu; Hiroki Miyashita; Mayumi Abe; Takuya Moriya; Hideki Ohta; Hikaru Sonoda; Tooru Shimosegawa; Koichi Tabayashi; Yasufumi Sato
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-09       Impact factor: 8.311

8.  The Pfam protein families database.

Authors:  Marco Punta; Penny C Coggill; Ruth Y Eberhardt; Jaina Mistry; John Tate; Chris Boursnell; Ningze Pang; Kristoffer Forslund; Goran Ceric; Jody Clements; Andreas Heger; Liisa Holm; Erik L L Sonnhammer; Sean R Eddy; Alex Bateman; Robert D Finn
Journal:  Nucleic Acids Res       Date:  2011-11-29       Impact factor: 16.971

9.  HMMER web server: 2015 update.

Authors:  Robert D Finn; Jody Clements; William Arndt; Benjamin L Miller; Travis J Wheeler; Fabian Schreiber; Alex Bateman; Sean R Eddy
Journal:  Nucleic Acids Res       Date:  2015-05-05       Impact factor: 16.971

Review 10.  Cysteine cathepsins: from structure, function and regulation to new frontiers.

Authors:  Vito Turk; Veronika Stoka; Olga Vasiljeva; Miha Renko; Tao Sun; Boris Turk; Dušan Turk
Journal:  Biochim Biophys Acta       Date:  2011-10-12
View more
  12 in total

1.  Domain architecture of vasohibins required for their chaperone-dependent unconventional extracellular release.

Authors:  Tetsuya Kadonosono; Wanaporn Yimchuen; Takuya Tsubaki; Tadashi Shiozawa; Yasuhiro Suzuki; Takahiro Kuchimaru; Yasufumi Sato; Shinae Kizaka-Kondoh
Journal:  Protein Sci       Date:  2017-02-11       Impact factor: 6.725

2.  Molecular basis of vasohibins-mediated detyrosination and its impact on spindle function and mitosis.

Authors:  Shanhui Liao; Girish Rajendraprasad; Na Wang; Susana Eibes; Jun Gao; Huijuan Yu; Gao Wu; Xiaoming Tu; Hongda Huang; Marin Barisic; Chao Xu
Journal:  Cell Res       Date:  2019-06-06       Impact factor: 25.617

3.  Parthenolide Destabilizes Microtubules by Covalently Modifying Tubulin.

Authors:  Takashi Hotta; Sarah E Haynes; Teresa L Blasius; Margo Gebbie; Emily L Eberhardt; David Sept; Michael Cianfrocco; Kristen J Verhey; Alexey I Nesvizhskii; Ryoma Ohi
Journal:  Curr Biol       Date:  2021-01-21       Impact factor: 10.834

4.  Structural basis of tubulin detyrosination by VASH2/SVBP heterodimer.

Authors:  Chen Zhou; Ling Yan; Wen-Hui Zhang; Zhu Liu
Journal:  Nat Commun       Date:  2019-07-19       Impact factor: 14.919

5.  Structural basis of tubulin detyrosination by vasohibins.

Authors:  Faxiang Li; Yingjie Hu; Shutao Qi; Xuelian Luo; Hongtao Yu
Journal:  Nat Struct Mol Biol       Date:  2019-06-24       Impact factor: 15.369

6.  α-Tubulin detyrosination impairs mitotic error correction by suppressing MCAK centromeric activity.

Authors:  Luísa T Ferreira; Bernardo Orr; Girish Rajendraprasad; António J Pereira; Carolina Lemos; Joana T Lima; Clàudia Guasch Boldú; Jorge G Ferreira; Marin Barisic; Helder Maiato
Journal:  J Cell Biol       Date:  2020-04-06       Impact factor: 10.539

Review 7.  The roles of vasohibin and its family members: Beyond angiogenesis modulators.

Authors:  Hua Du; Jing Zhao; Ling Hai; Jing Wu; Hua Yi; Yonghong Shi
Journal:  Cancer Biol Ther       Date:  2017-09-08       Impact factor: 4.742

8.  Structural Analyses on the Deamidation of N-Terminal Asn in the Human N-Degron Pathway.

Authors:  Joon Sung Park; Jae-Young Lee; Yen Thi Kim Nguyen; Nae-Won Kang; Eun Kyung Oh; Dong Man Jang; Hyun-Jung Kim; Dae-Duk Kim; Byung Woo Han
Journal:  Biomolecules       Date:  2020-01-20

9.  Structural insights into tubulin detyrosination by vasohibins-SVBP complex.

Authors:  Xi Liu; Hao Wang; Jinying Zhu; Yongchao Xie; Xin Liang; Zeliang Chen; Yue Feng; Yi Zhang
Journal:  Cell Discov       Date:  2019-12-31       Impact factor: 10.849

10.  Closing the tubulin detyrosination cycle.

Authors:  Anna Akhmanova; Helder Maiato
Journal:  Science       Date:  2017-12-15       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.